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Paraptosis is a type of programmed cell death that is characterized by dilation of the
endoplasmic reticulum (ER) and/or mitochondria. Since paraptosis is morphologically
and biochemically different from apoptosis, understanding its regulatory mechanisms
may provide a novel therapeutic strategy in malignant cancer cells that have proven
resistant to conventional pro-apoptotic treatments. Relatively little is known about
the molecular basis of paraptosis, but perturbations of cellular proteostasis and
ion homeostasis appear to critically contribute to the process. Ca2+ transport has
been shown to be important in the paraptosis induced by several natural products,
metal complexes, and co-treatment with proteasome inhibitors and certain Ca2+-
modulating agents. In particular, the Ca2+-mediated communication between the ER
and mitochondria plays a crucial role in paraptosis. Mitochondrial Ca2+ overload from
the intracellular Ca2+-flux system located at the ER–mitochondrial axis can induce
mitochondrial dilation during paraptosis, while the accumulation of misfolded proteins
within the ER lumen is believed to exert an osmotic force and draw water from the
cytoplasm to distend the ER lumen. In this process, Ca2+ release from the ER also
critically contributes to aggravating ER stress and ER dilation. This review focuses on
the role of Ca2+ transport in paraptosis by summarizing the recent findings related to
the actions of Ca2+-modulating paraptosis-inducing agents and discussing the potential
cancer therapeutic strategies that may effectively induce paraptosis via Ca2+ signaling.
Keywords: paraptosis, Ca2+, endoplasmic reticulum, mitochondria, cancer
INTRODUCTION
The term “paraptosis” was first introduced to describe a form of programmed cell death displaying
cytoplasmic vacuolation consisting in mitochondrial and/or endoplasmic reticulum (ER) dilation
(Sperandio et al., 2000). Paraptosis was initially observed in 293T cells and mouse embryonic
fibroblasts overexpressing insulin-like growth factor 1 receptor (IGF-1R) (Sperandio et al., 2000)
and was subsequently shown to be induced by different natural compounds in vitro and in vivo
in tumor cells (Lee et al., 2016; Fontana et al., 2020b). In addition, paraptosis appears to be
implicated in neurodegeneration (Wei et al., 2015). Paraptosis lacks apoptotic features (e.g., DNA
condensation and fragmentation, membrane blebbing, and apoptotic bodies), and unlike necrosis,
no loss of membrane integrity is seen in paraptosis (Sperandio et al., 2000, 2004). As the underlying
mechanisms of paraptosis, impaired proteostasis (due to proteasomal inhibition or disrupted
protein thiol homeostasis), and/or imbalanced homeostasis of ions (e.g., Ca2+ and K+) have been
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proposed to trigger stress to the ER and mitochondria (Lee et al.,
2016; Fontana et al., 2020b). Paraptosis is successfully inhibited
by the translation inhibitor, cycloheximide (CHX) (Sperandio
et al., 2000), suggesting that inhibition of protein synthesis may
prevent this cell death by reducing the potential burden of
misfolded proteins and proteotoxicity (Lee et al., 2016). The
activation of mitogen-activated protein (MAP) kinases, such as
c-Jun N-terminal protein kinases (JNKs), MAP kinase kinase 2
(MEK-2), and p38, has been found to be positively involved in
the paraptosis induced by many natural products or chemicals
(Zhang et al., 2009, 2010; Yoon et al., 2010, 2012, 2014; Wang
et al., 2012; Yumnam et al., 2014; Hager et al., 2018; Han
et al., 2018; Fontana et al., 2019; Yokoi et al., 2020), whereas
AIP-1/Alix appears to be negatively involved in some cases
of paraptosis (Sperandio et al., 2004; Valamanesh et al., 2007;
Yoon et al., 2010, 2014; Han et al., 2018; Xue et al., 2018). The
term “paraptosis-like cell death” has been used to describe the
types of cell death accompanied by the dilation of either the
mitochondria or the ER alone or those that do not share multiple
biochemical features of paraptosis, including the activation
of MAP kinases, the downregulation of AIP-1/Alix, and the
inhibition of vacuolation and cell death by cycloheximide, etc.
(Zhang et al., 2010; Xue et al., 2018; Kim et al., 2019). Recently,
Ca2+ depletion in the ER and the subsequent mitochondrial
Ca2+ overload have been shown to play a critical role in the
paraptosis induced by various natural products and chemicals
(Yoon et al., 2012, 2014; Yumnam et al., 2016; Kim et al., 2019).
Here we review the recent understanding of paraptosis, focusing
on the involvement of intracellular Ca2+ transport in paraptosis,
provide mechanistic insight into the Ca2+-mediated regulatory
pathways of paraptosis, and finally discuss the cancer therapeutic
strategy of inducing paraptosis by manipulating intracellular
Ca2+ homeostasis.
THE MACHINERY INVOLVED IN THE
ER-MITOCHONDRIA Ca2+ TRANSPORT
The ER and mitochondria both participate in regulating
intracellular Ca2+ homeostasis due to their ability to store
Ca2+ and respond to cytosolic Ca2+ signals. Under normal
physiological conditions, the concentrations of both cytosolic
Ca2+ and Ca2+ stored within the ER lumen are strictly regulated.
The cytosolic Ca2+ concentration [(Ca2+)c] is approximately
0.1 µM, compared to an extracellular (Ca2+) of ∼1 mM and
an ER Ca2+ concentration [(Ca2+)er] of ∼0.5 mM (Bianchi
et al., 2004). The import of Ca2+ into the ER is governed by
sarcoplasmic/ER Ca2+ ATPase (SERCA) pumps (Vandecaetsbeek
et al., 2011). In response to cellular stress requiring Ca2+-
signal, Ca2+ is released from ER stores via ryanodine receptors
(RyRs) and (especially) inositol 1,4,5,-triphosphate receptors
(IP3Rs) (Marks, 1997); the latter are primarily clustered in the
mitochondria-associated membrane (MAM), an ER structure
that is located near the mitochondria (Rizzuto et al., 1998;
Csordás et al., 1999; Bartok et al., 2019). The mitochondria
serve as important regulators of cellular Ca2+ by sequestering
and releasing Ca2+. The Ca2+ concentration (Ca2+) inside
the mitochondria has similar values measured in the bulk
cytoplasm (0.1–0.2 µM) under resting conditions; however,
mitochondrial Ca2+ concentration increased 10—20-fold more
than the cytosolic compartment during stimulation with (Ca2+)-
increasing agents (Giorgi et al., 2018). In particular, Ca2+ ions
released from the ER by IP3Rs or RyRs flux across the outer
mitochondrial membrane (OMM) mainly through the voltage-
dependent anion channel (VDAC) (Gincel et al., 2001; Rapizzi
et al., 2002). After reaching the intermembrane space, Ca2+ ions
pass through the inner mitochondrial membrane (IMM) mainly
through the mitochondrial Ca2+ uniporter (MCU) complex
(Baughman et al., 2011; De Stefani et al., 2011). This MCU
complex consists of two pore-forming proteins; mitochondrial
calcium uptake protein (MCU)1–3 (Baughman et al., 2011; De
Stefani et al., 2011) and essential MCU regulator (Sancak et al.,
2013); the dominant-negative pore-forming subunit, MCUb
(Raffaello et al., 2013), and the scaffolding factor, mitochondrial
calcium uniporter regulator 1 (MCUR1) (Mallilankaraman et al.,
2012; Tomar et al., 2016). The activity of the MCU complex
is regulated by mitochondrial calcium uptake 1 (MICU1)
(Perocchi et al., 2010) and its paralog MICU2 (Plovanich
et al., 2013); they together comprise the MCU complex, which
allows for mitochondrial Ca2+ uptake exclusively at high Ca2+
concentrations (Patron et al., 2014). Therefore, the MCU complex
has been proposed to be the key player responsible for the
rate-limiting step of mitochondrial Ca2+ accumulation, and it
may be pivotal to Ca2+-overload-induced cell death. The Ca2+
taken up by the mitochondria is rapidly extruded into the
cytosol via a complex antiporter system to restore the basal
state. The mitochondrial Na+/Ca2+ exchanger (mNCX) and the
mitochondrial H+/Ca2+ exchanger (mHCX) play major roles
in mitochondrial Ca2+ efflux mechanisms. The stoichiometry
of mNCX-driven transport is electrogenic, with three (or four)
Na+ for one Ca2+ (Jung et al., 1995; Dash and Beard, 2008),
whereas the exchange ratio of mHCX is electroneutral (two
H+ for one Ca2+) (Gunter et al., 1991). The mitochondrial
permeability transition pore (mPTP) has been also proposed to
be involved as an alternative Ca2+ efflux pathway under certain
conditions when the mPTP is transiently opened (Elrod et al.,
2010; Lu et al., 2016).
PARAPTOSIS-INDUCING AGENTS
ASSOCIATED WITH Ca2+ IMBALANCE
The natural products and chemicals that are listed in Table 1
induce paraptosis. During this process, they disrupt Ca2+
homeostasis at the ER by altering Ca2+ store content and
Ca2+ dynamics (including the uptake, release, and leakage of
Ca2+) and/or at the mitochondria by affecting the activities of
MCU complex components to regulate the mitochondrial Ca2+
levels. In addition, recent studies have shown that treatment of
cancer cells with drugs that perturb Ca2+ homeostasis [CGP-
37157 (Yoon et al., 2012), lercanidipine (Lee et al., 2019),
and loperamide (Kim et al., 2019)] or Nutlin-3, which is
a chemical that triggers the mitochondrial unfolded protein
response (mtUPR) (Lee et al., 2017), induces paraptosis when
























TABLE 1 | Paraptotic inducers and their pro-paraptotic mechanisms of action.
Paraptotic inducers Cell death
mode
Dilated organelles Method(s) Ca2+-related mechanism Other mechanisms Tested cells References


























↑ MCU Proteasomal activity↓, poly-Ub↑,
ER stress↑, requirement of protein
















↑ MCU Proteasomal activity↓,
poly-Ub↑, ER stress↑,
requirement of protein synthesis,















↑ MCU ROS↑, mitochondrial superoxide↑,
MMP↓, p-ERK1/ 2↑











↑ ↑ VDAC ER stress↑, Alix/ AIP↓, ROS↑,
MMP↓











TEM ↑ ↑ VDAC ER stress↑, requirement of protein
synthesis, ROS↑, p-JNK↑, p-p38↑,
Akt/ mTOR↓








↑ Poly-Ub↑, ER stress↑, requirement
of protein synthesis, Alix/ AIP1↓,
ROS↑, MMP↓, p-ERK1/ 2↑
Prostate,
breast, lung








LM LM ↑ Influx of
extracellular
Ca2+
Requirement of protein synthesis,
MMP↓, p-ERK1/ 2↑, p-p38↑
Brain, liver,
leukemia















































TABLE 1 | Continued
Paraptotic inducers Cell death
mode
Dilated organelles Method(s) Ca2+-related mechanism Other mechanisms Tested cells References




































CHOP↑, MMP↓, p-JNK↑, p-ERK1/
2↑




Paraptosis ER/ mitochondria YFP-ER
LM
Probe ↑ Thiol homeostasis↓, CHOP↑,
MMP↓,
p-ERK1/ 2↑, p-MEK1/ 2↑






(50 µM + 15
nM)




CHOP↑, requirement of protein
synthesis, Alix/ AIP↓,
p-JNK↑, p-ERK1/ 2↑




(5∼15 µM + 4
nM)








↑ MCU Poly-Ub↑, ER stress↑,




























CCD-112CoN Kim et al.,
2019
Nutlin-3 + PI
(30 µM + 5
nM)










↑ MCU Proteostasis↓, poly-Ub↑, CHOP↑,







Normal cell line: MCF-10A, human mammary epithelial cell line; HMEC, primary mammary epithelial cells; Thle-2, primary normal liver cells by infection with SV40 large T antigen; RWPE-1, human prostatic epithelial
cells; IMR90, human lung fibroblast cells; Chang Liver, normal liver cell line; CCD-112CoN, human colon fibroblast cells; CCD-841CoN: human colon epithelial cells. TEM, transmission electron microscopy; LM, light
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combined with proteasome inhibitors (PIs). The proposed targets
through which these paraptosis-inducing agents disrupt Ca2+
homeostasis are summarized in Figure 1. In this section, we
will summarize and discuss their Ca2+-associated regulatory
effects in paraptosis.
Curcumin
Curcumin, the main natural polyphenol extracted from the
rhizomes of Curcuma longa, demonstrates chemopreventive
(Park et al., 2013), chemosensitizing, and radiosensitizing activity
in cancer cells (Goel and Aggarwal, 2010). Yoon et al. (2010)
showed that curcumin can induce paraptosis by promoting
vacuolization via the swelling and fusion of the mitochondria
and the ER in various breast cancer cell lines, but not in
normal breast cells. The curcumin-induced vacuolation and
cell death were effectively abrogated by the protein synthesis
blocker, cycloheximide. The authors found that impairment of
proteasome activity by curcumin is the main cause of paraptosis-
related ER stress and ER dilation and that mitochondrial Ca2+
overload is needed for mitochondrial dilation seen during
curcumin-induced paraptosis. More specifically, curcumin-
induced activation of RyRs mediates the release of Ca2+ from the
ER. Subsequently, MCU-mediated mitochondrial Ca2+ uptake
causes Ca2+ overload, contributing to the dilations of the
mitochondria and the ER, and cell death (Yoon et al., 2010).
These results suggest that mitochondrial Ca2+ overload is an
initial and important signal for curcumin-induced paraptosis.
The activations of ERK2 or JNKs were also found to critically
contribute to curcumin-induced paraptosis. Furthermore, the
protein levels of AIP-1/Alix were decreased by curcumin,
and AIP-1/Alix overexpression attenuated curcumin-induced
paraptosis (Yoon et al., 2010).
Celastrol
Celastrol, a quinone methide triterpene derived from Thunder
God Vine, exhibits antioxidant, antidiabetic, antiobesity, and
anti-tumor activity (Cascão et al., 2017). Celastrol has been
found to trigger paraptosis in various cancer cells (Yoon et al.,
2014). In HeLa cells, celastrol-induced paraptosis was found to
be accompanied by apoptosis and autophagy, suggesting that
different cellular fates could be induced by celastrol depending
on the cell type and/or cellular context (Wang et al., 2012).
Celastrol treatment of MDA-MB-435S cells was shown to induce
mitochondrial Ca2+ overload and ER stress. IP3R-mediated
Ca2+ release from the ER and its subsequent MCU-mediated
mitochondrial Ca2+ influx appear to be critically implicated
in celastrol-induced paraptosis. Mitochondrial Ca2+ overload
results in its functional defect and the generation of reactive
oxygen species (ROS), which further impair proteasome activity.
This proteasome-inhibiting activity of celastrol may stabilize
IP3R and MCU to reinforce the Ca2+-mediated effects of
celastrol, leading to ER stress, ER vacuolation, and subsequent
cell death (Yoon et al., 2014).
Hesperidin
Hesperidin, a flavanone glycoside present in citrus fruits, was
shown to kill HepG2 cells through the induction of paraptosis
accompanied by mitochondrial and ER swelling without
apoptotic features (Yumnam et al., 2014, 2016). Treatment with
hesperidin was found to increase the mitochondrial Ca2+ levels
in these cells, and MCU-mediated mitochondrial Ca2+ overload
was revealed to play an important role in hesperidin-induced
paraptosis. Ca2+-mediated increase in ROS generation was
shown to induce the hesperidin-induced loss of mitochondrial
membrane potential, and ERK1/2 activation was found to
positively influence hesperidin-induced vacuolation (Yumnam
et al., 2014, 2016). Both IP3R and RyR mediate the release of Ca2+
from the ER and subsequent MCU-mediated Ca2+ influx into the
mitochondria, thereby contributing to the paraptosis induced by
hesperidin in HepG2 cells (Yumnam et al., 2016).
Morusin
Morusin, a prenylated flavonoid isolated from the root bark
of Morus australis, exhibits anti-oxidant, anti-bacterial, and
anti-tumor properties (Zoofishan et al., 2018). Treatment of
epithelial ovarian cancer (EOC) cells with morusin triggers
paraptosis-like cell death accompanied by extensive cytoplasmic
vacuolation due to the dilation and fusion of the ER and the
mitochondria (Xue et al., 2018). Morusin induced mitochondrial
Ca2+ overload, accumulation of ER stress marker proteins,
ROS generation, and loss of the mitochondrial membrane
potential (MMP, 19m) in these cells. These morusin-induced
mitochondrial Ca2+ influx, ROS generation, MMP depletion,
cytoplasmic vacuolization, and cell death were suppressed by
a pretreatment with 4,4′-diisothiocyanostilbene-2,2′-disulfonic
acid (DIDS), an inhibitor of anion channels, including VDAC
(Jessen et al., 1986; Ben-Hail and Shoshan-Barmatz, 2016). In
addition, DIDS inhibited the morusin-induced antiproliferative
effects, which were associated with ER stress, both in vitro
and in vivo in ovarian cancer xenograft models. In conclusion,
morusin may have antitumor potential against EOC by inducing
paraptosis via VDAC-mediated mitochondrial Ca2+ overload
(Xue et al., 2018).
δ-Tocotrienol
δ-Tocotrienol (d-TT) induces paraptosis together with autophagy
and apoptosis in castration resistance prostate cancer (CRPC)
cells. d-TT-induced paraptosis was demonstrated by the reported
dilation of ER cisternae and swollen and damaged mitochondria
with disintegrated cristae (Fontana et al., 2019). δ-TT-induced
vacuolation was prevented by salubrinal (the ER stress inhibitor)
and cycloheximide (the protein synthesis inhibitor). δ-TT was
found to trigger significant impairments of mitochondrial
metabolic functions and structural dynamics (Fontana et al.,
2020a). In addition, δ-TT significantly increases the levels
of cytoplasmic Ca2+, mitochondrial Ca2+, and ROS, which
contribute to the pro-death activities (paraptosis, apoptosis, and
autophagy) of this agent in these cells. Pretreatment with the
VDAC inhibitor, DIDS, significantly attenuated the effects of δ-
TT on cell viability (paraptosis and apoptosis), suggesting that
mitochondrial Ca2+ overload is critical for the anticancer activity
of δ-TT in CRPC cells (Fontana et al., 2020a).
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FIGURE 1 | The inducers of Ca2+-mediated paraptosis and their molecular targets. Paraptosis is induced by drugs targeting the activities of several Ca2+ channels
and transporters. The names of paraptotic inducers are given in colored boxes, and their potential targets are marked by arrows of corresponding colors. The figure
was produced using Biorender (biorender.com).
Chalcomoracin
Treatment with chalcomoracin (CMR), one of the major
secondary metabolites found in fungus-infected mulberry leaves,
induces mitophagy and a paraptosis that is accompanied by
extensive cytoplasmic vacuolation originated from the ER in
PC-3 and MDA-MB-231 cells (Han et al., 2018). In this
process, CMR treatment upregulated PTEN-induced kinase 1,
a key marker of mitophagy, and downregulated the protein
levels of AIP-1/Alix, an inhibitory protein of paraptosis. CMR-
induced ROS generation and MMP loss were effectively inhibited
by a pretreatment with the antioxidant, N-acetylcysteine
(NAC). Moreover, increases in the level of Ca2+ and the
activation of the Ca2+-activated protease, calpain, preceded
CMR-induced cytoplasmic vacuolation, and a pretreatment
with the intracellular Ca2+ chelator, BAPTA-AM, blocked
CMR-induced cytoplasmic vacuolation. These findings together
suggest that ROS-mediated impairment of MMP and Ca2+
homeostasis may contribute to CMR-induced paraptotic cell
death (Han et al., 2018).
Procyanidins
Oligomeric procyanidins (F2), which are abundant in grape
seeds, can induce paraptosis in U-87 cells (Zhang et al., 2009).
Apoptotic features were not observed in cells treated with F2.
However, a further study indicated that activation of the ERK1/2
and p38 pathways, as well as Ca2+ mobilization, was involved in
the F2-mediated cell death of U-87 cell (Zhang et al., 2010).
Iturin A-Like Lipopeptides
Iturin A-like lipopeptides produced by Bacillus subtillis were
reported to simultaneously induce paraptosis, apoptosis,
and autophagy in heterogeneous human epithelial colorectal
adenocarcinoma (Caco-2) cells (Zhao et al., 2019). Induction
of paraptosis in Caco-2 cells was shown by cytoplasmic
vacuolization accompanied by ER dilation and swelling as well
as mitochondrial dysfunction. The antitumor effect of the iturin
A-like lipopeptides on Caco-2 cells was decreased by more than
50% in the presence of an apoptosis inhibitor, suggesting that
paraptosis may play a crucial role in its anticancer activity.
A significant increase in Ca2+ and ROS levels was also observed
with ER stress in cells (Zhao et al., 2019).
Triscyclometalated Iridium(III)
Complex-Peptide Hybrids 4
Yokoi et al. (2020) demonstrated that the amphiphilic iridium
complex-peptide hybrid (IPH) 4, which contains a glycolic acid
moiety between the iridium core and the peptide part, induces
paraptosis-like cell death in Jurkat cells (Yokoi et al., 2020).
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The authors found that IPH4 increased the influx of Ca2+ from
the ER to the mitochondria and induced the subsequent loss of
MMP (19m), resulting in vacuolization of the cytoplasm and
intracellular organelles (Yokoi et al., 2020).
Me2NNMe2
Me2NNMe2, which is a new derivative of α-N-heterocyclic
thiosemicarbazones, induces major hallmarks of paraptotic
cell death, including ER-derived vacuolation, mitochondrial
swelling, activation of MEK/ERK signaling pathway, and caspase-
independent cell death (Hager et al., 2018). In this process, the
copper complex of Me2NNMe2 accumulates in the ER to inhibit
the reductive potential of protein disulfide isomerase (PDI). The
resultant disruption of thiol redox homeostasis in the ER, in turn,
activates protein kinase R (PKR)-like endoplasmic reticulum
kinase signaling and the release of Ca2+ ions from the ER. This
prolonged Ca2+ imbalance triggers the swelling of the ER and the
mitochondria as well as mitochondrial membrane depolarization,
leading to cell death (Hager et al., 2018).
CGP-37157 + Proteasome Inhibitor
Yoon et al. (2012) showed that proteasome inhibition alone is
not effective to kill breast cancer cells. However, the CGP-37157-
mediated inhibition of mNCX could sensitize breast cancer
cells (but not normal cells) to a PI by inducing paraptosis
accompanied by dilation of both the mitochondria and the ER
(Yoon et al., 2012). In addition, co-treatment of CGP-37157
enhanced bortezomib (Btz)-mediated ER stress, ERK activation,
JNK activation, and AIP-1/Alix downregulation. While the
mitochondrial Ca2+ levels were transiently increased by CGP-
37157 alone, CGP-37157/Btz induced a sustained mitochondrial
Ca2+ overload. A pretreatment with ruthenium red significantly
inhibited the cell death induced by CGP-37157/Btz, possibly
by inhibiting the influx of Ca2+ into the mitochondria. These
findings together indicate that the simultaneous inhibition of
the proteasome and mNCX effectively induces paraptosis via
mitochondrial Ca2+ overload and that dilations of the ER and
the mitochondria seem to be interdependent during paraptosis
(Yoon et al., 2012).
Lercanidipine + Proteasome Inhibitor
A recent study showed that lercanidipine (Ler), a third-
generation 1,4-dihydropyridine (DHP) used to treat high blood
pressure, potentiates the antitumor effects of various PIs (e.g.,
Btz, carfilzomib, and ixazomib) in many solid cancer cell lines by
inducing paraptosis, a cell death mode accompanied by extensive
vacuolation derived from the ER and the mitochondria (Lee et al.,
2019). Ler enhances Btz-mediated ER stress and ER dilation in
MDA-MB 435S cells. Mitochondrial Ca2+ overload was followed
by the increase in cytosolic Ca2+ levels in cancer cells treated
with Ler and Btz. Mechanistic studies employing various Ca2+
antagonists revealed that an MCU-mediated mitochondrial Ca2+
overload may be critical for Ler/Btz-induced mitochondrial
dilation, subsequent ER dilation, and cell death. In contrast, an
increase in cytosolic Ca2+ contributes solely to ER dilation at
the later phase of Ler/Btz treatment. As the possible underlying
mechanism, the authors proposed that the Ler/Btz-mediated
stabilization of DHP receptor and RyR may result in the release
of Ca2+ from the ER and the subsequent MCU-mediated
mitochondrial Ca2+ uptake. This sustained mitochondrial Ca2+
overload may cause mitochondrial dilation and prompt opening
of mPTP, leading to the leakage of Ca2+ into the cytosol
(Lee et al., 2019).
Loperamide + Proteasome Inhibitor
Kim et al. (2019) showed that the widely used anti-diarrheal drug,
loperamide (Lop), effectively enhances the cytotoxicity of PIs in
various colon cancer cells, but not in normal colon epithelial cells
(Kim et al., 2019). The combination of sublethal concentrations
of Btz and Lop (Lop/Btz) effectively triggered paraptosis-like
cell death accompanied by severe vacuolation derived from the
ER in various colon cancer cells, whereas either agent alone
failed to induce notable vacuolation or cell death. In Lop/Btz-
treated cancer cells, mitochondrial fragmentation was observed.
Lop enhances Btz-mediated ER stress and ER dilation due to
misfolded protein accumulation, leading to the upregulation of
C/EBP homologous protein (CHOP) and subsequent paraptosis-
like cell death. In addition, Btz/Lop increased both cytosolic
and mitochondrial Ca2+ levels. An increase in Ca2+ (possibly
by an influx of extracellular Ca2+) appears to play a critical
role in the anticancer effects of Lop/Btz by affecting ER-derived
vacuolation. Mitochondrial Ca2+ overload also contributes to
Lop/Btz-mediated cytotoxicity, although it does not affect the
dilations of the ER and the mitochondria (Kim et al., 2019).
Nutlin-3 + Proteasome Inhibitor
The small molecule mouse double minute 2 homolog antagonist,
Nutlin-3, exhibits promising therapeutic anti-cancer activity
(Vassilev et al., 2004; Vassilev, 2007). Lee et al. (2017) showed
that the combined treatment with Nutlin-3 and Btz triggered
the formation of megamitochondria and progressive fusion of
swollen ER, leading to paraptotic cell death in various p53-
defective Btz-resistant solid tumor cells (Lee et al., 2017). Neither
Nutlin-3 alone nor Btz alone did significantly affect the cellular
morphology and viability, although Nutlin-3 alone induced a
transient mitochondrial dilation. Mechanistically, proteasomal-
impairment-induced ER stress (particularly CHOP upregulation)
critically contributes to Nutlin-3/Btz-induced ER dilation and
subsequent cell death induced by Nutlin-3/Btz. In addition,
Nutlin-3/Btz, but not either agent alone, increased both cytosolic
and mitochondrial Ca2+ levels. An increase in cytosolic Ca2+,
possibly by an influx of extracellular Ca2+, plays an important
role in Nutlin-3/Btz-induced ER dilation and subsequent cell
death. For Nutlin-3/Btz-induced mitochondrial dilation, Nutlin-
3-mediated mitochondrial stress due to the accumulation of
misfolded proteins within the mitochondria may be more
important than mitochondrial Ca2+ overload (Lee et al., 2017).
INVOLVEMENT OF Ca2+ IN PARAPTOSIS
Role of Ca2+ in Mitochondrial Dilation
Mitochondrial dilation is a key morphological feature of
paraptosis, together with ER dilation (Sperandio et al., 2000).
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Mitochondrial dilation generally includes both mitochondrial
swelling and their fusion to form megamitochondria (giant
mitochondria) in paraptosis (Yoon et al., 2010, 2012, 2014;
Yumnam et al., 2014; Lee et al., 2017; Fontana et al., 2019;
Zhao et al., 2019). Mitochondrial swelling is defined as an
increase in mitochondrial volume due to an influx of fluid and
is known to occur first by expansion of the intracristal space
and later by swelling of the matrix compartment (Trump and
Ginn, 1968). Some degree of mitochondrial swelling may occur
as a reversible, pre-lethal form of cellular damage (Halestrap,
1989; Lim et al., 2002). The mitochondria become enlarged
at most three times, by simple swelling, compared to their
original size (typically 0.5–1 µm in length). The size of the
dilated mitochondria, including megamitochondria (with width
and length > 1 µm) (Lee et al., 2017; Wieczorek et al., 2017;
Palma et al., 2019), in paraptosis often exceed those of swollen
mitochondria observed during apoptosis or necrosis. Swollen
mitochondria can be distinguished from megamitochondria by
other morphological features, in addition to the degree of
enlargement. Swollen mitochondria are seen to be round with
pale matrix and cristae are observed only on the periphery,
whereas the shape of megamitochondria in early stages are
often irregular and the density of their matrix appears well
maintained (Teranishi et al., 1999). When megamitochondria
are further swollen, they are seen with a pale matrix and
their cristae are detected only on the periphery. Previously, a
treatment with Ca-SANDOZ reportedly induce the formation
of megamitochondria in brown adipocyte of Wistar rats (Golic
et al., 2014), but the exact role and the regulatory mechanism
of megamitochondria formation in paraptosis remain to be
clarified. In the paraptosis induced by hesperidin (Yumnam
et al., 2016), δ-TT (Fontana et al., 2020a), IPH4 (Yokoi et al.,
2020), and iturin A-like lipopeptides (Zhao et al., 2019), the
mitochondria undergo swelling and show cristae disintegration
and loss. On the other hand, megamitochondria formation due
to the fusion of mitochondria is observed in the paraptosis
induced by curcumin (Yoon et al., 2010), celastrol (Yoon et al.,
2014), CGP-37157/Btz (Yoon et al., 2012), and Nutlin-3/Btz
(Lee et al., 2017).
Ca2+ and K+ play important roles in the physiological
and pathological swelling of the mitochondria. Imbalances of
these ions between the cytosol and matrix increase the osmotic
pressure and enhance the water influx, leading to matrix swelling
(Kaasik et al., 2007; Javadov et al., 2018). The transport of
Ca2+ and K+ across the IMM is associated with influx/efflux
mechanisms for other ions, such as Na+, Cl−, and H+ (Halestrap
et al., 1986; Halestrap, 1994; Kaasik et al., 2007; Javadov et al.,
2018). This complex interplay between mitochondrial swelling
and ion homeostasis maintains the mitochondrial function
and metabolism under physiological conditions. Mild Ca2+-
mediated increases in matrix volume over the physiological range
can promote oxidative phosphorylation and electron transfer
chain and thus help satisfy the metabolic requirements of the
cell (Halestrap, 1987, 1989; Lim et al., 2002). In addition,
changes in IMM fluidity due to the altered mitochondrial
shape and membrane tension may affect the activity of ion
channels and other transporters, including the mechanosensitive
mitochondrial large-conductance Ca2+-activated K+ channel
(Walewska et al., 2018). Therefore, a slight increase of the matrix
volume can regulate mitochondrial function and metabolism,
possibly representing an adaptive response to protect the
mitochondria against severe oxidative stress and delaying the
onset of cell death. On the other hand, massive Ca2+ release
from the ER causes the prolonged mitochondrial Ca2+ overload
and excessive mitochondrial swelling (Rovere et al., 2016; Marchi
et al., 2018). Mitochondrial Ca2+ overload has been commonly
reported in paraptosis-associated cell death by curcumin (Yoon
et al., 2012), celastrol (Yoon et al., 2014), hesperidin (Yumnam
et al., 2016), morusin (Xue et al., 2018), δ-TT (Fontana et al.,
2020a), IPH4 (Yokoi et al., 2020), Me2NNMe2 (Hager et al.,
2018), CGP-37157/PI (Yoon et al., 2012), Ler/PI (Lee et al.,
2019), Lop/PI (Kim et al., 2019), and Nutlin-3/PI (Lee et al.,
2017). Among them, the functional significance of MCU-
mediated mitochondrial Ca2+ overload as an early signal for
paraptosis was confirmed by the reports that pharmacological
and/or genetic inhibition of MCU attenuates the mitochondrial
dilation and subsequent paraptotic cascades (i.e., ER stress,
ER dilation, and subsequent cell death) induced by curcumin
(Yoon et al., 2012), celastrol (Yoon et al., 2014), hesperidin
(Yumnam et al., 2016), CGP-37157/PI (Yoon et al., 2012),
and Ler/PI (Lee et al., 2019). VDAC-mediated mitochondria
Ca2+ uptake was shown to be involved in morusin- or δ-TT-
induced paraptotic cell death (Xue et al., 2018; Fontana et al.,
2020a). The source of overloaded Ca2+ in the mitochondria
was the ER (Yoon et al., 2012, 2014; Lee et al., 2019); RyR
is reportedly involved in the release of Ca2+ from the ER in
curcumin- or Ler/PI-induced paraptosis (Yoon et al., 2012; Lee
et al., 2019), whereas IP3R was involved in that process during
celastrol-induced cell death (Yoon et al., 2014). In addition,
both RyR and IP3R were reported to mediate the release
of Ca2+ from the ER during hesperidin-induced paraptosis
(Yumnam et al., 2016). Furthermore, inhibition of the mNCX-
mediated Ca2+ efflux from the mitochondria can contribute to
mitochondrial Ca2+ accumulation and subsequent paraptotic
events (Yoon et al., 2012). The combination of PI and the
mNCX inhibitor, CGP-37157, induces paraptosis accompanied
by sustained mitochondrial Ca2+ overload, mitochondrial
dilation, ER stress, and ER dilation (Yoon et al., 2012).
Collectively, these results suggest that an excessive Ca2+
overload in the mitochondria not only triggers mitochondrial
dilation but also contributes to subsequent paraptotic events
including ER dilation.
Role of Ca2+ in ER Dilation
Appropriate maintenance of the intraluminal homeostasis in the
ER is needed to keep the cellular viability, and ER dilation is
the most common morphological feature of paraptosis (Yoon
et al., 2010, 2012, 2014; Yumnam et al., 2014; Lee et al., 2017,
2019; Hager et al., 2018; Xue et al., 2018; Fontana et al.,
2019; Kim et al., 2019). Regarding the involvement of Ca2+
in paraptosis, Ca2+ depletion within the ER can contribute to
ER dilation during paraptosis. Maintenance of sufficient Ca2+
levels within the ER is crucial for the function of components
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of the protein folding machinery, such as chaperones and
folding enzymes; this is because the chaperone activities of
the molecular chaperones, Ig binding protein (Bip)/glucose-
regulated protein 78 (GRP78), PDI, GRP94, and ERp57/PDIA3,
are regulated by the binding of Ca2+ (Prins and Michalak,
2011; Carreras-Sureda et al., 2018). Therefore, alteration of the
Ca2+ concentration within the ER by activation of IP3R or
RyR can contribute to ER stress and ER dilation by causing
incorrect protein folding and an accumulation of misfolded
proteins. Mimnaugh et al. (2006) showed that geldanamycin/Btz
induces ER-derived vacuolation and proposed that this effect
was due to a massive accumulation of misfolded proteins within
the ER lumen. The authors believed that this would exert
an osmotic force, resulting in the induction of an influx of
water from the cytoplasm and the distension of the ER into
vacuoles. The increased ER volume provided by ER-derived
vacuolation may reduce the amount of misfolded proteins in
the ER and facilitate their utilization, providing cells with
an adaptive cellular response under mild stress (Mimnaugh
et al., 2006). However, long-term unresolved ER stress may
trigger extensive fusion among the swollen ER membranes and
subsequently irreversible ER-derived vacuolation, resulting in
an ER-associated degradation-compromised condition and cell
death (Shubin et al., 2016). Recent studies have shown that
impairment of protein thiol homeostasis also plays a critical role
in plumbagin-induced paraptosis-associated cell death (Binoy
et al., 2019), likewise with gambogic acid (Seo et al., 2019),
ophiobolin A (Kim et al., 2017), and PDTC/doxorubicin (Park
et al., 2018). These paraptosis-inducing agents commonly harbor
highly electrophilic features that are used to covalently modify
free sulfhydryl or hydroxyl groups on proteins, causing protein
misfolding, misfolded protein accumulation in the ER lumen, ER
stress, and ER dilation (Kim et al., 2017; Park et al., 2018; Seo et al.,
2019). The thiol-reactivity of these agents may be responsible
for their inhibitory effects on proteasomal activity; in fact, most
paraptosis-inducing agents demonstrate proteasome inhibitory
activity (Yoon et al., 2010, 2014; Wang et al., 2012). In addition,
the copper complex of Me2NNM2-mediated PDI inhibition
was shown to be responsible for the induction of paraptosis
by the disruption of the ER protein thiol homeostasis (Hager
et al., 2018). The authors proposed that disruption of the ER
thiol redox homeostasis by PDI inhibition contributes to Ca2+
release from the ER, organelle swelling, mitochondrial membrane
depolarization, and subsequent cell death. Collectively, these
findings suggest that the cross-modulation between imbalanced
Ca2+ in the ER and impaired proteostasis may be part of the
progression of paraptosis.
Ca2+-Mediated Communication
Between the ER and the Mitochondria in
Paraptosis
During the progression of paraptosis, the dilation of the
mitochondria and the ER appears to be interdependently
controlled, although mitochondrial dilation generally precedes
ER dilation. Based on reports indicating that intracellular
Ca2+ transport is involved in the paraptosis induced by
various triggers, the following hypothetical model of the
mechanisms underlying Ca2+-mediated paraptosis can be
proposed (Figure 2).
The regulation of Ca2+ signaling by the ER depends on
SERCA-mediated Ca2+ uptake activity (Vandecaetsbeek et al.,
2011), the expression of luminal Ca2+ binding proteins, and
the activity of Ca2+ release channels, including IP3R and RyR
(Marks, 1997; Rovere et al., 2016). As an initial step of Ca2+-
mediated paraptosis, Ca2+ is released from the ER to the MAM
through IP3Rs or RyRs. The subsequent uptake of Ca2+ by
the mitochondria is driven by the difference of membrane
potential generated by the respiratory chain, which provides the
electrochemical force needed for positively charged ions, such as
Ca2+, to enter the mitochondrial matrix (Giorgi et al., 2018).
VDAC at the OMM (Gincel et al., 2001; Rapizzi et al., 2002)
and MCU at the IMM mediate the uptake of Ca2+ into the
mitochondria (Baughman et al., 2011; De Stefani et al., 2011).
Mild mitochondrial Ca2+ uptake can activate the tricarboxylic
acid cycle and electron transport chain, triggering mitochondrial
ROS generation and the release of H2O2 at the MAM (Feissner
et al., 2009; Rizzuto et al., 2012). This may provide positive
feedback to IP3Rs, enhancing their ability to sustain the
release of Ca2+ from the ER and promote mitochondrial Ca2+
uptake. Furthermore, ER hyperoxidation due to thiol-oxidizing
compounds also can promote Ca2+ release by opening of Ca2+
channels in the ER and inhibiting SERCA, thereby indirectly
contributing to ER stress (Lizák et al., 2020). Interestingly, ROS
generation was often associated with the paraptosis induced by
Ca2+ homeostasis-perturbing drugs, including curcumin (Yoon
et al., 2010), hesperidin (Yumnam et al., 2016), morusin (Xue
et al., 2018), δ-TT (Fontana et al., 2020a), and chalcomoracin
(Han et al., 2018), as shown in Table 1. However, the paraptosis
induced by various drugs with thiol reactivity due to their high
electrophilic nature, including Me2NNM2 (Hager et al., 2018),
plumbagin (Binoy et al., 2019), gambogic acid (Seo et al., 2019),
and ophiobolin A (Kim et al., 2017), was not correlated with ROS
generation despite the fact that their vacuolation and cell death
were successfully inhibited by the thiol-containing antioxidants.
These results suggest that a thiol-dependent mechanism, rather
than ROS, is critical for the anti-cancer activities of these drugs.
When considering the role of Ca2+ in mitochondrial dilation,
it is notable that, at the early phase of paraptosis, Ca2+-
mediated mitochondrial dilation may represent an adaptive
response aimed at facilitating the removal of Ca2+ released
from the ER and regulating the mitochondrial matrix volume
by relieving stress to support the functional and morphological
integrity of the mitochondria and delay the onset of cell death.
The phenomenon of the formation of megamitochondria at
the initial phase of paraptosis could be also considered as an
adaptive process at the organelle level to unfavorable conditions,
although further studies are definitely needed to prove this
hypothesis. However, prolonged Ca2+ influx from the ER may
exceed the loading capacity of the mitochondria; this could cause
mitochondrial depolarization and compromise mitochondrial
function, ultimately resulting in irreversible cell death. In support
of this hypothesis, several studies have shown that mitochondrial
Ca2+ overload triggers the production of ROS, which can further
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FIGURE 2 | Hypothetical model for Ca2+-mediated communication between the mitochondria and the endoplasmic reticulum (ER) in paraptosis. Ca2+ is released
from the ER through IP3Rs or RyRs and taken up into the mitochondria via voltage-dependent anion channel and mitochondrial Ca2+ uniporter. Mild mitochondrial
Ca2+ uptake activates the tricarboxylic acid cycle and electron transfer chain, leading to ATP synthesis and reactive oxygen species (ROS) generation; this generates
a positive feedback on IP3Rs and induces the further release of Ca2+ from the ER and its uptake into the mitochondria. However, prolonged Ca2+ overload in the
mitochondria triggers mitochondrial membrane potential loss, mPTP opening, and the influx of water to the matrix, leading to mitochondrial swelling. The
mitochondria cease to take up Ca2+ because there is no electrochemical gradient in the mitochondrial membrane, while the ER fails to take up Ca2+ because
sarcoplasmic/ER Ca2+ ATPase is inhibited by ROS and ATP shortages. This increases the cytosolic Ca2+ level. In addition, excessive depletion of Ca2+ in the ER
hampers the actions of chaperones, which depend on Ca2+ binding to promote protein folding in the ER; this contributes to the accumulation of misfolded proteins,
leading to the water-influx-based distention of the ER lumen. This Ca2+-mediated vicious cycle between the ER and the mitochondria further expands mitochondria-
and ER-derived vacuoles, leading to irreversible structural and functional defects in these two organelles and eventual cell death. The figure was produced using
Biorender (biorender.com).
promote opening of mPTP (Hajnóczky et al., 2006; Görlach
et al., 2015). This results in mitochondrial swelling because it
allows water, ions, and other solutes to enter the matrix and
equilibrate the solutes on both sides of the IMM (Kaasik et al.,
2007; Javadov et al., 2018). Subsequent dissipation of the MMP
results in uncoupling of oxidative phosphorylation and metabolic
collapse. At the same time, loss of MMP might reduce the
mitochondrial capacity to retain Ca2+, resulting in increased
cytosolic Ca2+ levels. In addition, cytosolic Ca2+ cannot be taken
up into the ER due to the shortage of ATP, which is required
for the ability of SERCA to pump Ca2+ into the ER. As a result,
Ca2+ is severely depleted in the ER; this leads to the accumulation
of misfolded proteins in the ER lumen, contributing to further
ER dilation. Expansion of the luminal space of the ER and the
subsequent fusion of swollen ER progress to the point that most
of the cellular space is occupied by large ER-derived vacuoles.
Thus, sequential and multifactorial cross-modulation among
mitochondrial Ca2+, ROS, and 11(9m may contribute to the
sequential and cooperative dilation of the mitochondria and the
ER in paraptosis.
INVOLVEMENT OF OTHER IONS IN
PARAPTOSIS
In addition to the disruption of Ca2+ homeostasis, imbalances
of other ions, including K+ and Cl−, are reportedly involved in
paraptosis. Previously, Hoa et al. (2007) reported that human
monocytes/macrophages induce paraptotic cell death in human
glioma cells expressing macrophage colony-stimulating factor;
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this occurs via activation of BKCa channels, which are found
at the ER and the mitochondria. The authors hypothesized
that, when BKCa channels open, K+ is expelled in exchange
for the entry of Na+ to maintain the electroneutrality of
the cell. The entry of Na+ results in the uptake of water,
generating the observed cellular swelling and vacuolation (Hoa
et al., 2007). Conversely, however, ophiobolin A was shown to
induce paraptosis-like cell death in human glioblastoma cells
by inhibiting BKCa channel activity (Bury et al., 2013). These
authors proposed that BKCa inactivation would presumably
induce the accumulation of K+ in the ER and the mitochondria,
leading to the increased osmotic pressure responsible for
vacuolation. Subsequently, opening of Ca2+ channels present in
the membrane or the ER may also contribute to the paraptotic
cascade. Future work will be needed to investigate how both
the activation of BKCa and its inhibition can induce paraptosis.
Furthermore, an increase in intracellular Cl− concentration by
the activation of chloride intracellular channel-1 (CLIC1) was
shown to be involved in the paraptosis induced by a purified resin
glycoside fraction (RFP) of Pharbitidis Semen (Zhu et al., 2019).
Blockade of CLIC1 by DIDS (an inhibitor of anion channels)
attenuated ER stress, cytoplasmic vacuolization, and cell death,
suggesting that CLIC1 may act as a critical and early signal in
RFP-induced paraptosis. Taken together, these results indicate
that the movements of both cations and anions can contribute
to the induction of paraptosis.
DISCUSSION
The inherent or acquired resistance of tumor cells to apoptosis
is a major hurdle limiting successful anticancer therapy and
the cause of many cancer-related deaths (Holohan et al.,
2013). Therefore, targeting cancer cells by the induction of an
alternative caspase-independent cell death pathway (Mathiasen
and Jäättelä, 2002), such as paraptosis, offers the opportunity
to overcome apoptosis resistance in cancer cells. Rapidly
proliferating and aneuploid cancer cells demand a much higher
level of protein-folding activity in the ER, compared to normal
cells (Deshaies, 2014). Additionally, cancer cells exhibit greater
oxidative stress than normal cells due (at least partially) to
oncogenic activation and altered mitochondrial activity (Gupta
et al., 2011). Since paraptosis-inducing agents simultaneously
target both the mitochondria and the ER, which are already under
stress in cancer cells, therapeutic strategies aimed at inducing
paraptosis may offer a two-pronged attack strategy to selectively
kill cancer cells.
Although various models have been proposed to classify
programmed cell death, exclusive definitions are difficult to
conceptualize and probably factitious, given the crosstalk
between cell death signaling pathway (Bröker et al., 2005).
In addition, some morphological and biochemical features are
shared in different cell death modes. Excessive swelling due to
prolonged mitochondrial Ca2+ overload was reported to be able
to induce apoptosis or necrosis, depending on the availability
of ATP (Rovere et al., 2016; Marchi et al., 2018). In apoptosis,
mitochondrial outer membrane permeabilization is critical for
the release of cytochrome c and other molecules, leading to the
activation of caspases (Green and Kroemer, 1998). Although
mitochondrial swelling is also an important morphological
feature of paraptosis, no release of mitochondrial cytochrome
c (Valamanesh et al., 2007; Gandin et al., 2012; Yoon et al.,
2014) and/or AIF (Valamanesh et al., 2007) into the cytosol
was shown in several models of paraptosis. In addition, no
requirement of caspases has been reported in many studies on
paraptosis (Lee et al., 2016; Fontana et al., 2020b). Mitochondrial
swelling is also a key feature of oncosis, the cell death mode
accompanied by cellular swelling, organelle swelling, blebbing,
and increased membrane permeability, resulting in bursting of
the plasma membrane (Majno and Joris, 1995; Weerasinghe
and Buja, 2012). However, paraptosis is not associated with cell
swelling. Furthermore, obvious damage to the OMM has not
been shown in transmission electron microscopy pictures of cells
undergoing paraptosis (Yoon et al., 2010, 2014; He et al., 2018;
Xue et al., 2018; Yokoi et al., 2020). MMP was fairly maintained
in the progression of paraptosis, but its loss was detected at
the excessively expanded megamitochondria at the late stage
of paraptosis (Lee et al., 2019; Seo et al., 2019). Reduced ATP
synthesis is also observed following the extensive vacuolation
derived from the mitochondria and/or the ER in paraptosis (He
et al., 2018; Binoy et al., 2019; Nedungadi et al., 2019). Therefore,
we presume that swelling and fusion of the mitochondria at the
pre-lethal phase may provide an adaptive response that helps
maintain mitochondrial membrane integrity and function before
leading to irreversible paraptotic cell death. Further studies on the
detailed changes in the structure/function of the mitochondria as
well as the relationship between Ca2+ imbalance and the integrity
of mitochondrial membrane during the progression of paraptosis
will be helpful to clearly understand paraptosis and clarify the
differences among various cell death modes accompanied by
mitochondrial Ca2+ overload and swelling.
While curcumin (Yoon et al., 2010), celastrol (Yoon et al.,
2014), hesperidin (Yumnam et al., 2014), IPH4 (Yokoi et al.,
2020), and Me2NNMe2 (Hager et al., 2018) induce paraptosis
independently of apoptosis and/or autophagy in the tested cancer
cells, several agents, including δ-tocotrienol (Fontana et al.,
2019, 2020a), chalcomorain (Han et al., 2018), and iturin A-like
lipopeptides (Zhao et al., 2019), induce not only paraptosis
but also simultaneous apoptosis and/or autophagy, as shown
in Table 1. It is intriguing to speculate why the same agent
can induce different cellular fates in some types of cells. The
cellular response to a cytotoxic drug can be affected by various
factors, including the type and dose of the drug, the extent of
cytotoxic stress exerted to the cells, and the cellular context. It
has been shown that more than one kind of cell death program
can be activated at the same time (Unal-Cevik et al., 2004).
The dominant cell death phenotype may be determined by the
relative speed and effectiveness of the available death programs:
In response to cellular damage, the characteristics of several
death pathways can be exhibited, but in general, only the most
effective and the fastest pathway is evident (Bröker et al., 2005).
Furthermore, cellular heterogeneity (even within the same cell
line) can contribute to the ability of a given drug to induce
different cell death modes (Inde and Dixon, 2018). We now
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know that many cancer cells are not homogeneous in nature
but rather contain a variety of cells with different characteristics
(Meacham and Morrison, 2013; Dagogo-Jack and Shaw, 2018).
Thus, the presence of heterogeneous populations of cancer cells
may yield different drug sensitivities, treatment resistances, and
the induction of different or mixed types of cell death modes.
Although the molecular basis of paraptosis needs further
investigation, many reports have indicated that impaired
proteostasis is critical for the induction of paraptosis, as
evidenced by the accumulation of poly-ubiquitinated proteins
and ER stress marker proteins as well as the ability of the protein
synthesis blocker to effectively inhibit vacuolation and cell death
(Lee et al., 2016; Fontana et al., 2020b). As shown in Table 1,
various chemicals have been shown to induce Ca2+ imbalance-
mediated paraptosis. Interestingly, these Ca2+ homeostasis-
disrupting drugs also induced proteostatic impairment, leading
to the accumulation of poly-ubiquitinated proteins and ER
stress marker proteins. Genetic or pharmacological inhibition of
Ca2+ imbalance effectively blocked this proteostatic impairment
and subsequent paraptosis (Yoon et al., 2010, 2014). These
results suggest that disruption of Ca2+ homeostasis may
negatively affect cellular proteostasis and enhance proteotoxicity,
contributing to paraptosis. Pretreatment with CHX almost
completely inhibited Ca2+ release from the ER, mitochondrial
Ca2+ overload, disruption of proteostasis, and subsequent
paraptotic events (Yoon et al., 2010, 2012; Yumnam et al.,
2014; Lee et al., 2019). Taken together, these results suggest that
Ca2+ imbalance and proteostatic disruption are interdependently
regulated during the progression of paraptosis. In addition,
simultaneous disruption of Ca2+ homeostasis and proteostasis,
rather than induction of Ca2+ imbalance or proteostatic
disruption alone, may be an effective means to kill cancer cells
by inducing paraptosis (Yoon et al., 2012; Kim et al., 2019;
Lee et al., 2019).
Btz, the first PI approved by FDA for clinical application,
has shown efficacy in both front-line and relapsed/refractory
settings, but its use can be limited by the development of
resistance and/or side effects. The principal dose-limiting toxic
effects of Btz are peripheral neuropathy, thrombocytopenia,
neutropenia, fatigue, and diarrhea (Dou and Zonder, 2014).
In addition, the PIs have shown limited clinical efficacy as
monotherapies for solid tumors (Huang et al., 2014). However,
Ca2+ homeostasis-perturbing drugs, such as lercanidipine,
loperamide, and CGP-37157, act together with PIs to induce
paraptosis (Yoon et al., 2012; Kim et al., 2019; Lee et al.,
2019). Treatment with these Ca2+ homeostasis-perturbing drugs
alone slightly and transiently induced mitochondrial dilation
without dilation of the ER, whereas treatment with the PIs
alone was not enough to induce paraptosis in these studies. It
is possible that either Ca2+ imbalance or proteasome inhibition
may trigger cellular adaptive responses, including the autophagy,
UPR, and reactivation of the ubiquitin–proteasome system,
contributing to the restoration of cellular homeostasis and
viability (Cooper et al., 1997; Brostrom and Brostrom, 2003;
Ding et al., 2007). Additionally, the proteasome is involved in
the degradation of both IP3R (Oberdorf et al., 1999) and RyR
(Pedrozo et al., 2010); thus, the PI-mediated stabilization of
these Ca2+ channels may induce the enhanced and sustained
release of Ca2+ from the ER in cells treated with these
Ca2+ homeostasis-perturbing drugs, contributing to the effective
induction of paraptosis. A combination of Ca2+ homeostasis-
perturbing drugs and PIs may therefore effectively induce
paraptosis by triggering a vicious cycle of ER–mitochondria
Ca2+ signaling. Furthermore, the combined regimen of a PI
plus Ca2+-modulating clinical drugs may provide us many
advantages, including enhanced therapeutic effectiveness, better
safety due to the reduced side effects of a PI by the use of
its lower dose, and the potential to expand the applicability
of PIs to solid tumors (Kim et al., 2019; Lee et al., 2019).
Therefore, induction of paraptosis through modulation of Ca2+
signaling may provide a novel therapeutic strategy to overcome
the resistance of solid tumors against PIs in the future. It
will be intriguing to explore the processes/regulatory pathways
underlying the differences between ER and mitochondrial Ca2+
transfer in cancer cells vs. normal cells under paraptosis-
inducing conditions. Further investigation of the regulatory
mechanisms of Ca2+ in paraptosis may provide new insights into
paraptosis and potential therapeutic strategies for the treatment
of resistant cancer.
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